Factors Influencing Depressive Symptoms in the Post-COVID-19 Pandemic Period.

Cureus

Department of Psychological Science, Graduate School of Humanities, Kwansei Gakuin University, Nishinomiya, JPN.

Published: October 2024

AI Article Synopsis

Article Abstract

Background Mental health issues associated with the COVID-19 pandemic have been widely reported, with various influencing factors identified. However, factors affecting mental health in the post-pandemic period remain unclear. Therefore, this study aimed to investigate the factors influencing depressive symptoms during the COVID-19 post-pandemic period. Methods An online cross-sectional survey using convenience sampling was conducted from December 5, 2023 to December 8, 2023. Basic demographic information and social factors were evaluated using a custom-designed questionnaire. Depressive symptoms were measured with the Japanese version of the Hospital Anxiety and Depression Scale, personality traits were measured with the Japanese version of the Ten Item Personality Inventory, and stress coping strategies were measured with the Japanese version of the Brief Coping Orientation to Problems Experienced Inventory. Logistic regression analysis was performed to examine the impact of gender, age, occupation, subjective economic status, COVID-19 history, presence of pre-pandemic depressive symptoms, personality traits, and stress coping strategies on post-pandemic depressive symptoms by calculating ORs and CIs. All statistical analyses were performed using IBM SPSS Statistics for Windows, Version 29.0 (Released 2022; IBM Corp., Armonk, NY, USA). We set a statistical significance level of 0.05 (two-tailed). Results Among all participants (n = 838), lower subjective economic status (OR: 2.90, 95% CI: 1.99-4.24), frequent substance use (OR: 1.70, 95% CI: 1.17-2.46), higher self-blame (OR: 2.03, 95% CI: 1.39-2.95), higher levels of active coping (OR: 0.58, 95% CI: 0.38-0.88), higher acceptance (OR: 0.61, 95% CI: 0.38-0.98), and pre-pandemic depressive symptoms (OR: 16.84, 95% CI: 11.61-24.44) were significantly associated with post-pandemic depressive symptoms. Conclusions This study identified pre-pandemic depressive symptoms, lower subjective economic status, higher self-blame, and frequent substance use as risk factors for post-pandemic depressive symptoms. These findings suggest the need for social support, economic assistance, and mental health education to promote constructive stress management alternatives to substance use for the prevention of depression in the context of pandemics.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11586240PMC
http://dx.doi.org/10.7759/cureus.72394DOI Listing

Publication Analysis

Top Keywords

depressive symptoms
36
mental health
12
measured japanese
12
japanese version
12
subjective economic
12
economic status
12
pre-pandemic depressive
12
post-pandemic depressive
12
depressive
9
symptoms
9

Similar Publications

Objective: Technology can be combined with psychological interventions to support older adults with memory concerns. Using a bi-phasic design, cognitive rehabilitation (CR) was integrated with off-the-shelf technology and delivered to two people with cognitive impairment, and one care partner.

Method: Pre- and post-intervention assessments were completed for all participants.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to evaluate the feasibility of an exercise intervention for young people aged 13-17 with mild to moderate depression, comparing high-intensity exercise, low-intensity exercise, and social activities.
  • Participants were recruited through mental health services and schools, with the intervention delivered over 12 weeks by trained professionals.
  • Results showed a 71.4% retention rate and over 67% attendance, although only 14 participants were randomized from the initial referrals, indicating challenges in recruitment.
View Article and Find Full Text PDF

Non-ionotropic NMDAR signalling activates Panx1 to induce P2X4R-dependent long-term depression in the hippocampus.

J Physiol

December 2024

Department of Cell Biology & Anatomy, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

In recent years, evidence supporting non-ionotropic signalling by the NMDA receptor (niNMDAR) has emerged, including roles in long-term depression (LTD). Here, we investigated whether niNMDAR-pannexin-1 (Panx1) contributes to LTD at the CA3-CA1 hippocampal synapse. Using whole-cell, patch clamp electrophysiology in rat hippocampal slices, we show that a low-frequency stimulation (3 Hz) of the Schaffer collaterals produces LTD that is blocked by continuous but not transient application of the NMDAR competitive antagonist, MK-801.

View Article and Find Full Text PDF

[Experiences and subjective transformations: suffering and coercion in the use of psychotropic drugs in psychiatric treatment in Chile].

Salud Colect

December 2024

Doctor en Sociología. Académico, Departamento de Trabajo Social, Facultad de Ciencias Sociales, Universidad Alberto Hurtado, Santiago, Chile.

This article analyzes the impact of psychotropic drug use on individuals diagnosed with schizophrenia, bipolar affective disorder, and severe depression in Chile. Using a qualitative narrative approach, the experiences of 25 patients from 2018 to 2021 are examined. Participants describe how these medications, while effective in symptom control, generate psychological suffering and a sense of coercion in daily life.

View Article and Find Full Text PDF

Validation of the Spanish version of the Adjustment Disorder New Module-20 (ADNM-20) in a non-clinical sample.

BMC Psychol

December 2024

Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Background: There is a lack of self-report measures specifically designed for Adjustment disorder. One of the most widely used instruments is the Adjustment Disorder New Module (ADNM), which has already been validated in different countries. The aim of this study was to validate the Spanish version of the ADNM-20 with a non-clinical sample, including a comparison with a high-risk sample.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!